Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response.

Sarris J, Papakostas GI, Vitolo O, Fava M, Mischoulon D.

J Affect Disord. 2014 Aug;164:76-81. doi: 10.1016/j.jad.2014.03.041. Epub 2014 Apr 1.

PMID:
24856557
[PubMed - in process]
2.

Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with major depressive disorder: a 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial.

Jeon HJ, Fava M, Mischoulon D, Baer L, Clain A, Doorley J, DiPierro M, Cardoos A, Papakostas GI.

Int Clin Psychopharmacol. 2014 Nov;29(6):332-8. doi: 10.1097/YIC.0000000000000039.

PMID:
24815673
[PubMed - in process]
3.

Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial.

Papakostas GI, Shelton RC, Zajecka JM, Bottiglieri T, Roffman J, Cassiello C, Stahl SM, Fava M.

J Clin Psychiatry. 2014 Aug;75(8):855-63. doi: 10.4088/JCP.13m08947.

PMID:
24813065
[PubMed - in process]
4.

A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorder.

Mischoulon D, Price LH, Carpenter LL, Tyrka AR, Papakostas GI, Baer L, Dording CM, Clain AJ, Durham K, Walker R, Ludington E, Fava M.

J Clin Psychiatry. 2014 Apr;75(4):370-6. doi: 10.4088/JCP.13m08591.

PMID:
24500245
[PubMed - indexed for MEDLINE]
5.

Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.

Cooper JA, Tucker VL, Papakostas GI.

J Psychopharmacol. 2014 Feb;28(2):118-24. doi: 10.1177/0269881113514878. Epub 2013 Dec 18.

PMID:
24352716
[PubMed - in process]
6.

Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice.

Papakostas GI.

J Clin Psychiatry. 2014 Jan;75(1):8-14. doi: 10.4088/JCP.13r08710. Review.

PMID:
24345473
[PubMed - indexed for MEDLINE]
7.

Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.

Bauer M, Demyttenaere K, El-Khalili N, Thase ME, Papakostas GI, Szamosi J, Earley WR, Eriksson H.

Int Clin Psychopharmacol. 2014 Jan;29(1):16-25. doi: 10.1097/YIC.0000000000000011.

PMID:
24108148
[PubMed - indexed for MEDLINE]
8.

Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies.

Papakostas GI, Culpepper L, Fayyad RS, Musgnung J, Guico-Pabia CJ.

Int Clin Psychopharmacol. 2013 Nov;28(6):312-21. doi: 10.1097/YIC.0b013e3283638fbd.

PMID:
23881185
[PubMed - indexed for MEDLINE]
9.

Relationship between sleep disturbance and depression, anxiety, and functioning in college students.

Nyer M, Farabaugh A, Fehling K, Soskin D, Holt D, Papakostas GI, Pedrelli P, Fava M, Pisoni A, Vitolo O, Mischoulon D.

Depress Anxiety. 2013 Sep;30(9):873-80. doi: 10.1002/da.22064. Epub 2013 May 16.

PMID:
23681944
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy.

Thase ME, Montgomery S, Papakostas GI, Bauer M, Trivedi MH, Svedsäter H, Locklear JC, Gustafsson U, Datto C, Eriksson H.

Int Clin Psychopharmacol. 2013 May;28(3):113-20. doi: 10.1097/YIC.0b013e32835fb971.

PMID:
23485955
[PubMed - indexed for MEDLINE]
11.

A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.

Papakostas GI, Vitolo OV, Ishak WW, Rapaport MH, Zajecka JM, Kinrys G, Mischoulon D, Lipkin SH, Hails KA, Abrams J, Ward SG, Meisner A, Schoenfeld DA, Shelton RC, Winokur A, Okasha MS, Bari MA, Fava M.

J Clin Psychiatry. 2012 Dec;73(12):1541-7. doi: 10.4088/JCP.12m07670.

PMID:
23290327
[PubMed - indexed for MEDLINE]
12.

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

Papakostas GI, Shelton RC, Zajecka JM, Etemad B, Rickels K, Clain A, Baer L, Dalton ED, Sacco GR, Schoenfeld D, Pencina M, Meisner A, Bottiglieri T, Nelson E, Mischoulon D, Alpert JE, Barbee JG, Zisook S, Fava M.

Am J Psychiatry. 2012 Dec 1;169(12):1267-74. doi: 10.1176/appi.ajp.2012.11071114.

PMID:
23212058
[PubMed - indexed for MEDLINE]
13.

Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.

Iovieno N, Papakostas GI.

J Clin Psychiatry. 2012 Oct;73(10):1300-6. doi: 10.4088/JCP.11r07485. Review.

PMID:
23140647
[PubMed - indexed for MEDLINE]
14.

Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.

Mischoulon D, Lamon-Fava S, Selhub J, Katz J, Papakostas GI, Iosifescu DV, Yeung AS, Dording CM, Farabaugh AH, Clain AJ, Baer L, Alpert JE, Nierenberg AA, Fava M.

CNS Spectr. 2012 Jun;17(2):76-86. doi: 10.1017/S1092852912000430.

PMID:
22789065
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Folates and S-adenosylmethionine for major depressive disorder.

Papakostas GI, Cassiello CF, Iovieno N.

Can J Psychiatry. 2012 Jul;57(7):406-13. Review.

PMID:
22762295
[PubMed - indexed for MEDLINE]
16.

Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.

Mischoulon D, Alpert JE, Arning E, Bottiglieri T, Fava M, Papakostas GI.

J Clin Psychiatry. 2012 Jun;73(6):843-8. doi: 10.4088/JCP.11m07139. Epub 2012 May 15.

PMID:
22687580
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.

Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G.

Ann Pharmacother. 2012 May;46(5):642-9. doi: 10.1345/aph.1Q326. Epub 2012 May 1.

PMID:
22550279
[PubMed - indexed for MEDLINE]
19.

Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.

Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.

J Clin Psychiatry. 2011 Dec;72(12):1660-8. doi: 10.4088/JCP.10r06531.

PMID:
22244025
[PubMed - indexed for MEDLINE]
20.

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.

Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, Pi B, Thurmond L, Bilello JA.

Mol Psychiatry. 2013 Mar;18(3):332-9. doi: 10.1038/mp.2011.166. Epub 2011 Dec 13.

PMID:
22158016
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk